Literature DB >> 23646875

Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.

Artak Tovmasyan1, Tin Weitner, Huaxin Sheng, MiaoMiao Lu, Zrinka Rajic, David S Warner, Ivan Spasojevic, Julio S Reboucas, Ludmil Benov, Ines Batinic-Haberle.   

Abstract

The different biological behavior of cationic n class="Chemical">Fe and Mn pyridylporphyrins in Escherichia coli and mouse studies prompted us to revisit and compare their chemistry. For that purpose, the series of ortho and meta isomers of Fe(III) meso-tetrakis-N-alkylpyridylporphyrins, alkyl being methyl to n-octyl, were synthesized and characterized by elemental analysis, UV/vis spectroscopy, mass spectrometry, lipophilicity, protonation equilibria of axial waters, metal-centered reduction potential, E(1/2) for M(III)P/M(II)P redox couple (M = Fe, Mn, P = porphyrin), kcat for the catalysis of O2(•-) dismutation, stability toward peroxide-driven porphyrin oxidative degradation (produced in the catalysis of ascorbate oxidation by MP), ability to affect growth of SOD-deficient E. coli, and toxicity to mice. Electron-deficiency of the metal site is modulated by the porphyrin ligand, which renders Fe(III) porphyrins ≥5 orders of magnitude more acidic than the analogous Mn(III) porphyrins, as revealed by the pKa1 of axially coordinated waters. The 5 log units difference in the acidity between the Mn and Fe sites in porphyrin translates into the predominance of tetracationic (OH)(H2O)FeP complexes relative to pentacationic (H2O)2MnP species at pH ∼7.8. This is additionally evidenced in large differences in the E(1/2) values of M(III)P/M(II)P redox couples. The presence of hydroxo ligand labilizes trans-axial water which results in higher reactivity of Fe relative to Mn center. The differences in the catalysis of O2(•-) dismutation (log kcat) between Fe and Mn porphyrins is modest, 2.5-5-fold, due to predominantly outer-sphere, with partial inner-sphere character of two reaction steps. However, the rate constant for the inner-sphere H2O2-based porphyrin oxidative degradation is 18-fold larger for (OH)(H2O)FeP than for (H2O)2MnP. The in vivo consequences of the differences between the Fe and Mn porphyrins were best demonstrated in SOD-deficient E. coli growth. On the basis of fairly similar log kcat(O2(•-)) values, a very similar effect on the growth of SOD-deficient E. coli was anticipated by both metalloporphyrins. Yet, while (H2O)2MnTE-2-PyP(5+) was fully efficacious at ≥20 μM, the Fe analogue (OH)(H2O)FeTE-2-PyP(4+) supported SOD-deficient E. coli growth at as much as 200-fold lower doses in the range of 0.1-1 μM. Moreover the pattern of SOD-deficient E. coli growth was different with Mn and Fe porphyrins. Such results suggested a different mode of action of these metalloporphyrins. Further exploration demonstrated that (1) 0.1 μM (OH)(H2O)FeTE-2-PyP(4+) provided similar growth stimulation as the 0.1 μM Fe salt, while the 20 μM Mn salt provides no protection to E. coli; and (2) 1 μM Fe porphyrin is fully degraded by 12 h in E. coli cytosol and growth medium, while Mn porphyrin is not. Stimulation of the aerobic growth of SOD-deficient E. coli by the Fe porphyrin is therefore due to iron acquisition. Our data suggest that in vivo, redox-driven degradation of Fe porphyrins resulting in Fe release plays a major role in their biological action. Possibly, iron reconstitutes enzymes bearing [4Fe-4S] clusters as active sites. Under the same experimental conditions, (OH)(H2O)FePs do not cause mouse arterial hypotension, whereas (H2O)2MnPs do, which greatly limits the application of Mn porphyrins in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23646875      PMCID: PMC3731146          DOI: 10.1021/ic3012519

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  63 in total

1.  Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.

Authors:  Júlio S Rebouças; Ivan Spasojević; Ines Batinić-Haberle
Journal:  J Pharm Biomed Anal       Date:  2008-08-14       Impact factor: 3.935

2.  Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst.

Authors:  Csaba Szabó; Jon G Mabley; Suzanne M Moeller; Roman Shimanovich; Pál Pacher; László Virag; Francisco G Soriano; John H Van Duzer; William Williams; Andrew L Salzman; John T Groves
Journal:  Mol Med       Date:  2002-10       Impact factor: 6.354

3.  Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.

Authors:  Xiaodong Ye; Diane Fels; Artak Tovmasyan; Katherine M Aird; Casey Dedeugd; Jennifer L Allensworth; Ivan Kos; Won Park; Ivan Spasojevic; Gayathri R Devi; Mark W Dewhirst; Kam W Leong; Ines Batinic-Haberle
Journal:  Free Radic Res       Date:  2011-09-27

4.  Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.

Authors:  Galen M Pieper; Vani Nilakantan; Min Chen; Jing Zhou; Ashwani K Khanna; James D Henderson; Christopher P Johnson; Allan M Roza; Csaba Szabó
Journal:  J Pharmacol Exp Ther       Date:  2005-03-22       Impact factor: 4.030

5.  A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.

Authors:  Zrinka Rajic; Artak Tovmasyan; Ivan Spasojevic; Huaxin Sheng; Miaomiao Lu; Alice M Li; Edith B Gralla; David S Warner; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2012-02-13       Impact factor: 7.376

6.  Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants.

Authors:  G Ferrer-Sueta; I Batinić-Haberle; I Spasojević; I Fridovich; R Radi
Journal:  Chem Res Toxicol       Date:  1999-05       Impact factor: 3.739

7.  Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.

Authors:  Júlio S Rebouças; Gilson DeFreitas-Silva; Ivan Spasojević; Ynara M Idemori; Ludmil Benov; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2008-05-05       Impact factor: 7.376

Review 8.  High-valent iron in chemical and biological oxidations.

Authors:  John T Groves
Journal:  J Inorg Biochem       Date:  2006-03-03       Impact factor: 4.155

9.  Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.

Authors:  Ivan Kos; Júlio S Rebouças; Gilson DeFreitas-Silva; Daniela Salvemini; Zeljko Vujaskovic; Mark W Dewhirst; Ivan Spasojević; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2009-04-08       Impact factor: 7.376

Review 10.  Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.

Authors:  Artak Tovmasyan; Huaxin Sheng; Tin Weitner; Amanda Arulpragasam; Miaomiao Lu; David S Warner; Zeljko Vujaskovic; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Med Princ Pract       Date:  2012-10-16       Impact factor: 1.927

View more
  19 in total

1.  Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.

Authors:  Myron K Evans; Artak Tovmasyan; Ines Batinic-Haberle; Gayathri R Devi
Journal:  Free Radic Biol Med       Date:  2013-12-12       Impact factor: 7.376

2.  Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues.

Authors:  Zrinka Rajic; Artak Tovmasyan; Otávio L de Santana; Isabelle N Peixoto; Ivan Spasojevic; Silmar A do Monte; Elizete Ventura; Júlio S Rebouças; Ines Batinic-Haberle
Journal:  J Inorg Biochem       Date:  2017-01-05       Impact factor: 4.155

Review 3.  Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2018-08-28       Impact factor: 8.401

4.  A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.

Authors:  Artak Tovmasyan; Clarissa G C Maia; Tin Weitner; Sebastián Carballal; Romulo S Sampaio; Dominik Lieb; Robert Ghazaryan; Ivana Ivanovic-Burmazovic; Gerardo Ferrer-Sueta; Rafael Radi; Julio S Reboucas; Ivan Spasojevic; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2015-05-28       Impact factor: 7.376

5.  Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus.

Authors:  Hüseyin Taslı; Ayse Akbıyık; Nermin Topaloğlu; Vildan Alptüzün; Sülünay Parlar
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

6.  Novel amphiphilic cationic porphyrin and its Ag(II) complex as potential anticancer agents.

Authors:  Artak Tovmasyan; Nelli Babayan; David Poghosyan; Kristine Margaryan; Boris Harutyunyan; Rusanna Grigoryan; Natalia Sarkisyan; Ivan Spasojevic; Suren Mamyan; Lida Sahakyan; Rouben Aroutiounian; Robert Ghazaryan; Gennadi Gasparyan
Journal:  J Inorg Biochem       Date:  2014-06-27       Impact factor: 4.155

Review 7.  Simple biological systems for assessing the activity of superoxide dismutase mimics.

Authors:  Artak Tovmasyan; Julio S Reboucas; Ludmil Benov
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

Review 8.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

9.  Acid-base and electrochemical properties of manganese meso(ortho- and meta-N-ethylpyridyl)porphyrins: voltammetric and chronocoulometric study of protolytic and redox equilibria.

Authors:  Tin Weitner; Ivan Kos; Zoran Mandić; Ines Batinić-Haberle; Mladen Biruš
Journal:  Dalton Trans       Date:  2013-10-01       Impact factor: 4.390

10.  Anticancer therapeutic potential of Mn porphyrin/ascorbate system.

Authors:  Artak Tovmasyan; Romulo S Sampaio; Mary-Keara Boss; Jacqueline C Bueno-Janice; Bader H Bader; Milini Thomas; Julio S Reboucas; Michael Orr; Joshua D Chandler; Young-Mi Go; Dean P Jones; Talaignair N Venkatraman; Sinisa Haberle; Natalia Kyui; Christopher D Lascola; Mark W Dewhirst; Ivan Spasojevic; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2015-10-20       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.